Global investment heavyweight GMO has ventured into the exchange-traded fund (ETF) space with the launch of the GMO U.S. Quality ETF (QLTY) on the NYSE. This strategic move underscores GMO’s longstanding commitment to providing innovative investment solutions tailored to client needs. QLTY, the first in a potential series of ETFs, capitalizes on GMO’s more than 40 years of quality investing experience. The fund aims to invest in high-quality U.S. stocks, offering investors the advantages inherent in the ETF structure, including tax efficiency, daily transparency, and continuous liquidity.
Tom Hancock, Head of GMO Focused Equity and Portfolio Manager of QLTY, emphasized the value of investing in quality businesses, particularly in today’s market landscape marked by concerns about interest rates, inflation, and the potential for a recession. The launch of QLTY aligns with GMO’s overarching mission to address investment challenges in harmony with client needs, extending institutional-grade strategies with a keen focus on tax-advantaged and operationally efficient access. This milestone builds upon GMO’s rich legacy in quality investing, with QLTY drawing from the success of the $14 billion GMO Quality Strategy managed since 2004.